CDC advisers could reverse newborn hepatitis B vaccine recommendations
NeutralU.S News

- A group of advisers to the Centers for Disease Control and Prevention (CDC) is set to vote on potentially reversing the long-standing recommendation for newborns to receive a hepatitis B vaccination within 24 hours of birth. This decision could significantly alter vaccination protocols for infants in the United States.
- The outcome of this vote is crucial as it may impact public health strategies aimed at preventing hepatitis B, a serious liver infection that can lead to chronic disease and liver cancer. The CDC's recommendations often influence healthcare practices nationwide.
- This potential reversal comes amid ongoing discussions about vaccine safety and efficacy, particularly in light of recent changes in CDC messaging regarding vaccines and autism. The evolving stance on vaccine recommendations reflects broader societal debates about public health policies and parental choice in vaccination.
— via World Pulse Now AI Editorial System

